DVL3 and adenocarcinoma: Both DVL-3 mRNA and δ-catenin mRNA were significantly more likely to be expressed in malignant than in benign lung disease (P < 0.01), and the expressions of DVL-3 mRNA and δ-catenin mRNA were more likely to be positive than cytology in adenocarcinoma (P < 0.01).